投稿信息
投稿信息
審稿周期
投稿命中率
審稿費用
暫無數據
版面費用
暫無數據
中國人發表比例
2023年中國人文章占該期刊總數量暫無數據 (2022年為100.00%)
自引率
8.4 %
年文章數
2884
作者需知
暫無數據
NCBI查詢
期刊簡介
稿件收錄要求
稿件收錄要求
Published by Elsevier Science.
ISSN: 1368-8375.
Oral Oncology is an international interdisciplinary journal which draws together for the first time issues relating to the aetiopathogenesis, epidemiology, prevention and management of oral and perioral tumours and of oral disease in patients with malignancies. Papers are invited on the following aspects of cancers arising in the lip, tongue, mouth, salivary glands, pharynx, and the related bones, soft tissues, and lymph glands. (1) Natural history of oral cancer and pre cancer, basic pathology, mestastatic mechanisms. (2) Cellular and molecular markers for diagnosis and prognosis, oncogenes, viruses, growth factors, and adhesion molecules. (3) Epidemiology, risk factors, prevention, screening, and intervention. (4) Advances in imaging and other functional diagnostic modalities. (5) Surgical advances, lasers, photo dynamic therapy, cyro surgery, micro vascular surgery. (6) Multimodality treatment, radiotherapy, chemotherapy, immunotherapy, gene therapy. (7) Advances in reconstruction and rehabilitation, grafts, alloplasty, bone and connective tissue biology, osteoradionecrosis. (8) Teamwork in cancer care, quality of life, nursing, speech and swallowing therapy, nutrition, counselling, pain control, terminal care. (9) Oral effects of tumours at both local and distant sites and their treatment. Research data may be submitted as a paper, short communication or letter. The journal will consider negative results from well designed studies, which may be published as short communications or letters. Letters may be published as short communications. Letters that comment on an article previously published in the same journal or that express a viewpoint about oncology are also invited. All published papers and short communications, and selected letters containing research data are peer reviewed.
Oral Oncology is an international interdisciplinary journal which draws together for the first time issues relating to the aetiopathogenesis, epidemiology, prevention and management of oral and perioral tumours and of oral disease in patients with malignancies. Papers are invited on the following aspects of cancers arising in the lip, tongue, mouth, salivary glands, pharynx, and the related bones, soft tissues, and lymph glands. (1) Natural history of oral cancer and pre cancer, basic pathology, mestastatic mechanisms. (2) Cellular and molecular markers for diagnosis and prognosis, oncogenes, viruses, growth factors, and adhesion molecules. (3) Epidemiology, risk factors, prevention, screening, and intervention. (4) Advances in imaging and other functional diagnostic modalities. (5) Surgical advances, lasers, photo dynamic therapy, cyro surgery, micro vascular surgery. (6) Multimodality treatment, radiotherapy, chemotherapy, immunotherapy, gene therapy. (7) Advances in reconstruction and rehabilitation, grafts, alloplasty, bone and connective tissue biology, osteoradionecrosis. (8) Teamwork in cancer care, quality of life, nursing, speech and swallowing therapy, nutrition, counselling, pain control, terminal care. (9) Oral effects of tumours at both local and distant sites and their treatment. Research data may be submitted as a paper, short communication or letter. The journal will consider negative results from well designed studies, which may be published as short communications or letters. Letters may be published as short communications. Letters that comment on an article previously published in the same journal or that express a viewpoint about oncology are also invited. All published papers and short communications, and selected letters containing research data are peer reviewed.
